» Articles » PMID: 17918011

Prevalence and Incidence of Primary Biliary Cirrhosis Are Increasing in Finland

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 2007 Oct 6
PMID 17918011
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the epidemiology of primary biliary cirrhosis (PBC) in Finland and to evaluate whether the possible increase in prevalence was attributable to the increasing incidence, better survival, or both.

Material And Methods: The Hospital Discharge Register, pathology registers, and death certificates for the years 1988 99 were scrutinized, and the patients identified were followed-up for survival until 31 October 2004. The study area covered four university hospital districts: a total of 25 hospitals. The diagnosis of PBC was regarded as definite (or probable) if three (or two) of the following criteria were fulfilled: positive antimitochondrial antibodies, constantly elevated alkaline phosphatase, and compatible liver histology.

Results: In the total population of the study areas, the age-standardized prevalence of PBC increased during the study period from 103 (95% CI: 97-110) to 180 (172-189) per million inhabitants. Incidence increased from 12 (10-14) to 17 (15-20) per million inhabitants per year. The annual average increase in prevalence was 5.1% (4.2-5.9%, p <0.0001) and in incidence 3.5% (0.9%-6.0%, p =0.008). In gender-specific analyses among women, the prevalence of PBC increased from 161 (151-171) to 292 (277-207) per million during the study period and the incidence from 20 (16-24) to 27 (23-32) per million per year. The death rate was 4% per year and half the deaths were from liver-related causes. Survival after diagnosis during the study period lengthened.

Conclusions: The prevalence of PBC increased in Finland during 1988-99, owing to both the increased incidence and the prolonged survival.

Citing Articles

The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis.

Gazda J, Drazilova S, Janicko M, Jarcuska P Can J Gastroenterol Hepatol. 2021; 2021:9151525.

PMID: 34239845 PMC: 8238597. DOI: 10.1155/2021/9151525.


Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches.

Galoosian A, Hanlon C, Zhang J, Holt E, Yimam K J Clin Transl Hepatol. 2020; 8(1):49-60.

PMID: 32274345 PMC: 7132015. DOI: 10.14218/JCTH.2019.00049.


Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.

Galoosian A, Hanlon C, Tana M, Cheung R, Wong R Dig Dis Sci. 2019; 65(2):406-415.

PMID: 31489564 DOI: 10.1007/s10620-019-05809-x.


The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Hirschfield G, Dyson J, Alexander G, Chapman M, Collier J, Hubscher S Gut. 2018; 67(9):1568-1594.

PMID: 29593060 PMC: 6109281. DOI: 10.1136/gutjnl-2017-315259.


Incidence of Primary Biliary Cholangitis in a Rural Midwestern Population.

Kanth R, Shrestha R, Rai I, VanWormer J, Roy P Clin Med Res. 2017; 15(1-2):13-18.

PMID: 28487448 PMC: 5573520. DOI: 10.3121/cmr.2017.1351.